GlassScriptPhysician profile
Andrew M Herbst
NPI 1437198702
$2,425.25
in general payments reported to CMS, 2019-2025
21 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2020: $319 · 2021: $516 · 2022: $363 · 2023: $541 · 2024: $260 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $921.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $336.38 | 2019-2025 | Libtayo, Dupixent |
| Novartis Pharmaceuticals Corporation | $265.84 | 2019-2023 | |
| Genentech USA, INC. | $254.59 | 2019-2022 | |
| Leo Pharma INC. | $212.26 | 2019-2024 | Adbry |
| Sun Pharmaceutical Industries INC. | $145.93 | 2019-2023 | Winlevi, Absorica Ld |
| Organogenesis INC. | $141.53 | 2022-2025 | Cygnus Dual, Puraply |
| Amgen INC. | $140.34 | 2021-2024 | Otezla |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $127.64 | 2019-2021 | |
| Dermavant Sciences, INC. | $125.00 | 2023 | Vtama |
| Genzyme Corporation | $114.71 | 2021-2023 | |
| Abbvie INC. | $105.85 | 2019-2020 | |
| Pfizer INC. | $100.78 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $90.16 | 2019-2021 | |
| Incyte Corporation | $80.76 | 2023-2025 | Opzelura |
| Lilly USA, LLC | $38.10 | 2020-2024 | Ebglyss |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $33.76 | 2025 | Bimzelx |
| Vyne Pharmaceuticals INC. | $27.24 | 2020 | |
| Janssen Biotech, INC. | $24.43 | 2022 | |
| Arcutis Biotherapeutics, INC. | $23.51 | 2024 | Zoryve |
| Almirall LLC | $23.00 | 2020 | |
| Merck Sharp & Dohme LLC | $13.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Herbst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.